Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    October 27, 2014October 27, 2014

    Researchers Develop Novel Nanoparticle To Deliver Melanoma Drug

    News
    Researchers from Penn State College of Medicine have published results in the journal Molecular Cancer Therapeutics, titled “Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma”, showing ... Read more
    October 24, 2014October 24, 2014

    Phase I SBIR Grant Awarded to Radiomedix and Viewpoint MT For Metastatic Melanoma Theranostics

    News
    RadioMedix, Inc. and Viewpoint Molecular Targeting LLC have been awarded a grant by the Small Business Innovation Research (SBIR) program from the National Cancer Institute. This Phase I award of ... Read more
    October 23, 2014October 23, 2014

    Study Finds New Subpopulation of Melanoma Cells

    News
    In a recent study titled “Vascular channels formed by subpopulations of PECAM1+ melanoma cells”, published in Nature Communications, a team of researchers from the University of North Carolina School of Medicine, ... Read more
    October 22, 2014October 22, 2014

    Study Links Melanoma Thickness To Patient Death Rates

    News
    Researchers from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, have published a study in the Journal of Investigative Dermatology, titled “More people die from thin melanomas (<1mm) than thick melanomas ... Read more
    October 21, 2014October 21, 2014

    Study Shows DecisionDx-Melanoma Is An Accurate Gene Expression Profile Test

    News
    A study presented at the annual meeting of the American Society for Clinical Oncology has shown that DecisionDx-Melanoma (Castle Biosciences), a commercially available gene expression-profile (GEP) test, can be a useful ... Read more
    October 20, 2014October 20, 2014

    New Melanoma Drug Combination Improves Patient Survival Rate, According To Study

    News
    A recent study titled “Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma”, and presented at the 2014 European Society for Medical Oncology (ESMO) conference in Madrid, Spain, showed that patients with advanced ... Read more
    October 20, 2014October 20, 2014

    Melanoma Patients Often Carry TERT Promoter Mutations

    Melanoma, News
    A group at University Hospital Essen in German confirmed the commonality of mutations in the gene for telomerase reverse transcriptase (TERT) in patients with cutaneous melanoma through a new study ... Read more
    October 17, 2014October 17, 2014

    SIRT6 Is Not Protective In Skin Cancer

    News, Skin Cancer
    “One cancer’s threat is another cancer’s promoter” is the theme of a new study published in Cancer Research by the laboratory of Yu-Ying He, PhD, in the Department of Medicine, ... Read more
    October 16, 2014

    Melanoma Treatment Benefits From Injecting Oncolytic Viruses

    News
    Research presented at the European Society for Medical Oncology (ESMO) Congress 2014, Madrid, Spain, has revealed that oncolytic viruses, such as specific common cold or herpes simplex viruses, can have ... Read more
    October 15, 2014October 15, 2014

    Melanoma Cells Use LPA Gradient to Migrate Around Body

    Melanoma, News
    As melanoma is one of the fastest spreading, aggressive cancer types, researchers are constantly trying to understand melanoma cells in order to stop their spread in the body. At the ... Read more
    October 14, 2014October 14, 2014

    Understanding Mutations, micro-RNAs, and Melanoma at Toldeo University

    Melanoma, News, Skin Cancer
    At University of Toledo, the laboratories of Drs. Kam Yeung and Ivana de la Serna discovered a new explanation for aggressive melanoma. Ila Datar, a PhD graduate student in the ... Read more
    October 13, 2014October 13, 2014

    Parathyroid Hormone-Related Protein Suppression Against Melanoma Progression

    News
    Researchers from the Royal Victoria Hospital, Montréal, Canada, recently published a study in the Endocrine journal showing that the role of the Parathyroid Hormone-Related Protein (PTHrP) in melanoma invasion and metastasis is ... Read more
    October 10, 2014October 10, 2014

    Intense Focus on Melanoma At The ESMO 2014

    News
    The Presidential Symposium and the poster sessions at the European Society for Medical Oncology (ESMO) 2014 were mostly focused on melanoma studies. The meeting was held in Madrid, Spain, where ... Read more
    October 9, 2014October 9, 2014

    Studies Suggest Efficacy of Intralesional Injections for Melanoma Therapy

    News
    Three presentations during the “Melanoma and Other Skin Tumors” poster session at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid highlighted the efficacy of treating cutaneous melanoma ... Read more
    October 8, 2014October 8, 2014

    Provectus To Present PV-10 Clinical Data At The 2014 Beijing International Melanoma Congress

    News
    Provectus Biopharmaceuticals, Inc., a company specializing in developing oncology and dermatology therapies, has announced that clinical data on its investigative new drug PV-10 for the treatment of melanoma will be ... Read more
    October 7, 2014

    New Gigapixel High-Definition Camera For Skin Cancer Diagnosis

    News
    A team of researchers at Duke University in North Carolina, USA, have developed a gigapixel whole-body photographic camera capable of taking snapshots of the entire human body, enabling the caption ... Read more
    October 6, 2014

    Melanoma Incidence Linked to Socioeconomic Factors and Fashion Trends According to Study

    News
    A new study published in the American Journal of Public Health titled “More Skin, More Sun, More Tan, More Melanoma”, links cultural and historical forces to the increased incidence of ... Read more
    October 3, 2014

    Roche And GSK Melanoma Drug Combination Shows Similar Results

    News
    Results from recent clinical trials presented at the European Society of Medical Oncology annual congress in Madrid, showed that two of the new pill combinations for melanoma treatment from Roche ... Read more
    October 2, 2014

    Experimental Therapy Shows Promising Results in Melanoma

    News
    During the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, data from a clinical study assessing pembrolizumab for the treatment of melanoma showed promising activity and safety profiles. ... Read more
    October 1, 2014October 1, 2014

    Melanoma, Immunotherapy-Radiation Combination Therapy Continues To Show Promise

    News
    A new study addressing the effect of highly focused radiation in boosting the immune system to target and kill cancer cells upon combination with a novel type of immune-enhancing drug, was presented ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.